Board Member — Compensation Committee
Switzerland·Pharmaceuticals & Life Sciences·Posted 4 August 2026
SIX-listed life sciences company
Actively sourcing
A demand profile the Exchange is actively sourcing against. The sponsor is not confirmed on this board, and we say so rather than implying a signed mandate. Registering interest puts you in front of the sponsor when the brief converts.
The problem this seat exists to solve
Members of the compensation committee are elected individually by the general meeting under CO Art. 733, and shareholders vote bindingly on aggregate compensation. The company needs a member who can defend its pay architecture to international investors annually.
The remit
- Serve on the compensation committee, elected individually by shareholders
- Own the design and defence of executive pay architecture through the binding say-on-pay vote
- Contribute to the board's gender-composition response under CO Art. 734f
- Support investor engagement ahead of the annual general meeting
What the sponsor will not compromise on
- Remuneration-committee experience at a listed company in a major market
- Credibility with international institutional investors and proxy advisers
- Understanding of the Swiss binding say-on-pay regime
- Willingness to stand for individual re-election annually
Terms
- Engagement
- One-year term, elected individually and annually by the general meeting.
- Compensation
- CHF 180,000 – 280,000 a year including committee fee.
- Cross-border
- No residency test applies to a director. The company retains Swiss-domiciled signing authority separately under CO Art. 718(4).
- Time commitment in this market
- Typically 6–10 board meetings a year plus committees and a strategy retreat; SMI boards carry a heavier load than the headline count suggests.
Before you apply — Switzerland
No nationality test applies to a director. The company must be capable of being represented by someone domiciled in Switzerland, which an officer can satisfy — it does not have to be you or any other director.
- Residency test
- At least one person domiciled in Switzerland must have signing authority for the company (CO Art. 718(4)).
- Nationality test
- None.
- Work authorisation
- A non-executive director attending board meetings does not require a residence permit. Executive roles do, and non-EU/EFTA nationals face a quota system.
- Tenure limit once appointed
- No statutory cap. The Swiss Code of Best Practice asks boards to consider tenure in assessing independence and to disclose their reasoning.
Global ID Exchange
One registration. Every market your record travels to.
Registering against a single brief is fine. Registering once against your whole profile means you are read against every mandate that opens in the markets you can actually be appointed in — statutory, interim and advisory.